ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 96 filers reported holding ALX ONCOLOGY HLDGS INC in Q4 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $105 | -67.1% | 17,317 | -39.5% | 0.00% | – |
| Q1 2024 | $319 | -52.0% | 28,635 | -35.8% | 0.00% | – |
| Q4 2023 | $664 | +414.7% | 44,637 | +65.5% | 0.00% | – |
| Q3 2023 | $129 | -0.8% | 26,964 | +57.1% | 0.00% | – |
| Q2 2023 | $130 | +85.7% | 17,168 | +10.4% | 0.00% | – |
| Q1 2023 | $70 | -46.2% | 15,547 | +34.9% | 0.00% | – |
| Q4 2022 | $130 | -99.8% | 11,528 | +72.7% | 0.00% | – |
| Q3 2022 | $64,000 | +88.2% | 6,677 | +58.5% | 0.00% | – |
| Q2 2022 | $34,000 | -57.5% | 4,213 | -10.5% | 0.00% | – |
| Q1 2022 | $80,000 | – | 4,707 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $163,929,000 | 36.34% |
| Logos Global Management LP | 3,011,352 | $50,892,000 | 6.60% |
| Vivo Capital, LLC | 4,220,048 | $71,319,000 | 4.91% |
| Samsara BioCapital, LLC | 262,786 | $4,441,000 | 1.12% |
| Cormorant Asset Management, LP | 712,079 | $12,034,000 | 0.92% |
| Pier Capital, LLC | 394,443 | $6,666,000 | 0.85% |
| Redmile Group, LLC | 772,397 | $13,054,000 | 0.41% |
| Artal Group S.A. | 500,000 | $8,450,000 | 0.35% |
| Nan Fung Group Holdings Ltd | 41,950 | $709,000 | 0.34% |
| Orbimed Advisors | 621,700 | $10,507,000 | 0.17% |